Introduction
The measurement of drug concentrations in body fluids other than plasma is of increasing interest as it can lead to a greater knowledge of their distribution and tissue penetration. In particular, the clinical pharmacology and pharmacokinetics of antibiotics in vaginal secretions are areas of practical importance which have received little attention.
The concentration of antimicrobial agents in vaginal secretions probably follows the physicochemical aspects of non-ionic diffusion'; the pH gradient between plasma and vaginal fluid supports the application of this concept here.
Erythromycin is widely used in the treatment of non-specific infections. In this study, we determined the plasma concentrations in men and the plasma and for 24 hours at 37°C was used.2 A standard curve was constructed from six standard solutions of erythromycin in serum (0 05, 0-1, 0-25, 1, 2, and 3 Mg/ml) and the test samples were estimated from it. FItUORIMETRIC 
ASSAY
This was based on the method of Tserng and Wagner) using an Aminco (SPF-125) spectrofluorimeter.
Plasma samples For plasma samples, the l-ml test sample (diluted if known to be of high concentration) was estimated from a standard curve from five standard solutions prepared in plasma (0, 0 5, 1, 2, and 3 ,g/ml) in duplicate.
Vaginal washings For vaginal washings, the whole volume specimen (40 ml) was estimated using a standard curve from four standard solutions (0, 0-5, 1, and 2 M.g/ml) spiked (added) in blank vaginal washings in duplicate.
SUBJECTS AND SAMPLES
Nine men (aged 21-50 years) with gonococcal urethritis were given a 2-g oral dose of erythromycin stearate under supervision in the clinic; a 5-ml plasma sample was taken after one hour.
A Iliopoulou, R N Thin, and P Turner Eleven women (aged 12-35 years) with non-specific genital infection were given oral erythromycin stearate 250 mg four times daily for 10 days. Two hours after the last dose, vaginal washings were collected using a modification of the method described by Stamey and Condy.' A Cusco bivalve speculum was passed and the vagina washed out with four 10-ml aliquots of distilled water, giving a total of 40 ml of washings. A 5-ml plasma sample was then collected. Samples were only collected after the end of the last menstrual period, and no sample was taken if there was cervical or vaginal bleeding from any cause.
Results

PLASMA
A typical standard curve for erythromycin concentrations in plasma by the microbiological assay is shown in fig 1. At high concentrations small differences in the size of the zone of inhibition (50-70 mm) correspond to large differences in concentration (0 25-3 gg/ml). 
COMPARISON OF ASSAYS
The coefficient of variation (CV) in spiked plasma samples for the microbiological and fluorimetric assays from six separate assays for each concentration is given in table I. The CV with the fluorimetric method is poor at extremely low concentrations but is satisfactory at higher concentrations. The microbiological assay gives satisfactory precision at all concentrations. The correlation between fluorimetric and microbiological assays in plasma samples is shown in fig 4. The mean plasma concentrations (+ SE) of both groups of patients by both assays showed high concentrations in the men, whereas those in the women, although lower, were higher than the minimum inhibitory concentration (MIC) for sensitive organisms, which varies from <0-1 to about 2 jAg/ml ( fig 5) . 4 The concentrations in plasma and vaginal washings taken simultaneously from the 11 women two hours after the final 250-mg dose of 10 days' treatment, as estimated by the fluorimetric assay, were 0 -68±0 -15,Ag/ml and 0-50±0-16 lAg/40ml These microbiological and fluorimetric assays were developed to study the pharmacokinetics of erythromycin in relation to its penetration into body fluids and secretions. Evaluation of the two methods showed that the Sarcina lutea microbiological method was more sensitive in determining concentrations in plasma but not sensitive enough for determining those in vaginal washings. This was because the concentrations of erythromycin present in the A Iliopoulou, R N Thin, and P Turner 1-ml samples of vaginal washings, which is the specimen volume required for the assay, were extremely low and also because the specimens being assayed were not sterile. This assay should be restricted to sterile specimens.
In contrast, the fluorimetric assay has the property of extracting any measurable amount of drug from any sample volume, whether sterile or not. The fluorimetric assay can produce results within two hours, whereas the microbiological method takes at least 24 hours. The fluorimetric assay may be of more value for clinical purposes but it is more costly and requires experience.
The major differences in practical applications and technical limitations between these two assays are summarised in table II. The correlation between the two assays in determining plasma concentrations of erythromycin was satisfactory. Relatively high concentrations were present in the nine men one hour after a 2-g single dose; lower concentrations, but within the therapeutic range, occurred in the 11 women given erythromycin 250 mg four times daily for 10 days. Plasma concentrations do not predict the therapeutic efficacy of a drug but indicate its clinical effect. In this study all measurable plasma erythromycin concentrations were above the MIC for Neisseria gonorrhoeae, Fluorimetric and microbiological assays oferythromycin concentrations in plasma and vaginal washings 267 which is given as 0' 04-0 4 Mg/ml by Garrod and O'Grady.6 A recent survey of strains isolated in this hospital, however, gave the range as 0 03-0 25 Mg/ml (personal communication, 1980) . The MIC for Chlamydia trachomatis (the most notable organism found in the genital tract in non-specific genital infection) is 0* 03-0-12 Mg/ml.5
The concentration of erythromycin in the vaginal fluid was not measured directly, but the figure in ,ug/40 ml of washings provides an exact measure of the total quantity of erythromycin recovered from the vagina and may therefore also provide a guide to the concentration of drug in the target tract. Our figure, although not providing 
